4.9(top 5%)
impact factor
44.1K(top 1%)
papers
2.8M(top 0.1%)
citations
428(top 0.1%)
h-index
5.3(top 5%)
extended IF
52.1K
all documents
2.9M
doc citations
637(top 1%)
g-index

Top Articles

#TitleJournalYearCitations
1Index for rating diagnostic testsCancer19508,967
2Reporting results of cancer treatmentCancer19817,417
3National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usageCancer19823,546
4“Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric originCancer19533,148
5A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer19752,871
6Primary carcinoma of the liver.A study of 100 cases among 48,900 necropsiesCancer19542,709
7A 5‐decade analysis of 13,715 carcinoid tumorsCancer20032,513
8Occurrence and prognosis of extranodal lymphomasCancer19722,230
9The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinomaCancer19482,151
10Relation of tumor size, lymph node status, and survival in 24,740 breast cancer casesCancer19892,083
11Apoptosis. Its significance in cancer and cancer TherapyCancer19941,945
12Changing patterns in the incidence of esophageal and gastric carcinoma in the United StatesCancer19981,944
13Congestive heart failure in patients treated with doxorubicinCancer20031,931
14Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapyCancer20061,907
15Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patientsCancer19851,864
16The evolution of cancer of the colon and rectumCancer19751,861
17Osteosarcoma incidence and survival rates from 1973 to 2004Cancer20091,834
18Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotypeCancer20071,798
19Metastases in carcinoma.Analysis of 1000 autopsied casesCancer19501,794
20Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlationsCancer19941,754
21Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group studyCancer19871,740
22Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future ratesCancer20101,728
23An approach for the treatment of penile carcinomaCancer19771,639
24Follow-up study of thymomas with special reference to their clinical stagesCancer19811,615
25A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995Cancer19981,574
26A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysisCancer19811,542
27The National Cancer Data Base report on cutaneous and noncutaneous melanomaCancer19981,521
28The rapid assessment of fatigue severity in cancer patientsCancer19991,518
29Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphomaCancer19831,484
30Decitabine improves patient outcomes in myelodysplastic syndromesCancer20061,463
31Localized mediastinal lymph-node hyperplasia resembling thymomaCancer19561,462
32A clinicopathologic analysis of adriamycin cardiotoxicityCancer19731,451
33Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 casesCancer19861,436
34Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patientsCancer19961,433
35Malignant fibrous histiocytoma.An Analysis of 200 CasesCancer19781,427
36The role of radiotherapy in cancer treatmentCancer20051,332
37Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trialsCancer20091,313
38Epithelioid hemangioendothelioma a vascular tumor often mistaken for a carcinomaCancer19821,295
39Epidemiology of cancer of the colon and rectumCancer19711,274
40Skeletal complications of malignancyCancer19971,267
41Histopathology and prognosis of Wilms tumorResults from the first national wilms' tumor studyCancer19781,249
42Hepatitis B virus.The major etiology of hepatocellular carcinomaCancer19881,244
43Perspectives on cancer therapy-induced mucosal injuryCancer20041,241
44International Classification of Childhood Cancer, third editionCancer20051,212
45Small adenocarcinoma of the lung. Histologic characteristics and prognosisCancer19951,201
46Hyaline‐vascular and plasma‐cell types of giant lymph node hyperplasia of the mediastinum and other locationsCancer19721,195
47Assessing symptom distress in cancer patientsCancer20001,185
48The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patientsCancer19851,178
49The prevalence of pituitary adenomasCancer20041,169
50The PedsQL™ in pediatric cancerCancer20021,163